Moleculera Biosciences Revenue and Competitors

Oklahoma City, OK USA

Location

$6M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Moleculera Biosciences's total funding is $6M.

Employee Data

  • Moleculera Biosciences has 13 Employees.(i)
  • Moleculera Biosciences grew their employee count by -7% last year.

Moleculera Biosciences's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
Co-Founder, President and CEOReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Billing Manager/Administrative CoordinatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M860%N/AN/A
#2
$0.8M50%N/AN/A
#3
$17.4M1123%N/AN/A
#4
$0.8M40%N/AN/A
#5
$65.3M301-3%$42.5MN/A
#6
$7.9M193360%N/AN/A
#7
$2.8M14-7%N/AN/A
#8
$3.6M6058%$81MN/A
#9
$1.4M814%N/AN/A
#10
N/A13-7%$5.89MN/A
Add Company

What Is Moleculera Biosciences?

Moleculera Biosciences is a precision medicine company focused on identifying and directing treatment for immune-mediated causes of chronic debilitating disorders. Through our fully-accredited CLIA/COLA clinical laboratory, we specialize in molecular diagnostic testing for autoimmune neuroimmunology. As pioneers focusing on neuropsychiatric disorders caused by molecular mimicry, we offer the Autoimmune Brain Panel™, an aid to a physician’s diagnosis of autoimmune-based neuropsychiatric disorders.\n\nThe Autoimmune Brain Panel™ helps identify whether an individual’s neurologic/psychiatric symptoms, such as obsessive compulsive behaviors, tics, anxiety, attention deficit hyperactivity disorder, and sometimes behaviors associated with Autism Spectrum Disorders, could be caused by a treatable autoimmune condition triggered by common infections.

keywords:N/A

$6M

Total Funding

13

Number of Employees

N/A

Revenue (est)

-7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.2M130%N/A
#2
$2.4M138%N/A
#3
$1.5M1344%N/A
#4
$0.6M1363%N/A
#5
$2.9M130%N/A